$HROW 8-K SEC Filings

Filed On	Filing
05 Oct 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more First and Only FDA-Approved Nasal Spray for Dry Eye Disease Adds a Differentiated, Drop-Free Treatment Option to Harrow’s Growing Ocular Surface Franchise
04 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation
10 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
06 Aug 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
22 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2026	8-K: Regulation FD Disclosure
11 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
27 Mar 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
24 Mar 2026	8-K: Other Events
24 Mar 2026	8-K: Other Events
10 Mar 2026	8-K: Regulation FD Disclosure
02 Mar 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
02 Feb 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
18 Nov 2025	8-K: Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities +1 more
10 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
06 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
29 Sep 2025	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
26 Sep 2025	8-K: Regulation FD Disclosure
26 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
19 Sep 2025	8-K: Changes in Registrant's Certifying Accountant

Comments